[Translation] Safety, efficacy and immunity of recombinant nonavalent human papillomavirus (6/11/16/18/31/33/45/52/58) vaccine (Escherichia coli) in Chinese men aged 18-45 Original multicenter, randomized, double-blind, placebo-controlled phase III clinical trial
评价重组九价人乳头瘤病毒(6/11/16/18/31/33/45/52/58型)疫苗(大肠埃希菌)在中国18-45岁男性中的保护效力、免疫原性和安全性
[Translation] Evaluation of the protective efficacy and immunogenicity of recombinant nonavalent human papillomavirus (6/11/16/18/31/33/45/52/58) vaccine (Escherichia coli) in Chinese men aged 18-45 and security